NuVasive, CONMED Corporation, Zimmer Biomet, Smith & Nephew Companies Profiled in Joint Reconstruction Devices Market

Rapidly expanding aging population base along with increasing number of centenarians, estimated to reach around 4 million by 2050 across the globe will drive the demand for various joint replacement devices. With rising incidences of orthopaedic diseases such as Osteoarthritis and other musculoskeletal disorders that causes joint pain, stiffness and inflammation; the need to address them will only rise in near future. Also, increasing life expectancy especially in emerging economies is resulting in more cases related to joint disorders; therefore, the demand and adoption rate of the joint reconstruction devices must increase multi-folds, fuelling the market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2823

Knee joint replacement devices market valued around USD 7.8 billion in 2017. As per estimates, the total number of knee replacement surgeries across the globe are projected to grow at robust rate and by 2030, around 3.5 million procedures would be carried out annually. This rise in number of total knee replacement surgical procedures will lead to rising product demand, thereby boosting the joint reconstruction devices market growth over the projection period. Moreover, rising per capita healthcare expenditure in emerging economies should contribute to industry expansion.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Smith & Nephew
• Conformis
• Medtronic Spinal & Biologics
• DJO Global
• Microport Scientific Corp
• Globus Medical
• Waldemar Link GmbH & Co. KG
• Arthrex
• DePuy Synthes Companies
• Stryker
• Integra LifeSciences
• NuVasive
• CONMED Corporation
• Zimmer Biomet

Strict FDA approvals and regulations will affect the joint reconstruction devices market growth in near future. After many failed cases of artificial joint replacement implants in patients in Unites States, the Food and Drug Administration (FDA) tightened the regulations for all the manufacturers from producing and selling such joint replacement implants.
U.S. joint reconstruction devices market valued around USD 9.4 billion in 2017; such a high valuation is attributed to escalated number for joint reconstruction procedure. According to the study of American Academy of Orthopedic Surgeons (AAOS), in 2014, an estimated 4.7 million people in America had total knee replacement surgery (TKA) and around 2.5 million people have had total hip arthroplasty (THA). technological advancements, favorable insurance coverage policies and high disposable income will increase the number of total joint replacement surgeries, boosting the demand for joint reconstruction devices over the foreseeable future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2823

Joint Reconstruction Devices Market, by Joint
• Knee Replacement
• Product
• Primary Knee Systems
• Revision Knee Systems
• Partial Knee Systems
• Component
• Femoral Component
• Tibial Component
• Patellar Component

• Hip Replacement
• Product
• Primary Hip Reconstruction Devices
• Partial Hip Reconstruction Devices
• Revision Hip Reconstruction Devices
• Hip Resurfacing Devices
• Component
• Acetabular component
• Femoral Component

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.